Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
In this trial investigators propose to assess the dose dense, G-CSF supported sequential administration of 4 cycles of FEC followed by 4 cycles of docetaxel versus 6 cycles of docetaxel/cyclophosphamide as adjuvant chemotherapy in women with HER-2 negative, axillary lymph node positive breast cancer
Critère d'inclusion
- Breast Cancer